Thanks LED for pointing out the importance of CRP (inflammation biomarker) as a proxy for treatment effect in both class II and class III. Good to know Rex-L was also highly significant for class III with high CRP (thanks for correcting). That makes me smile even more.
How nice would it be (hopefully one day in the not too distant future) that Rex-L essentially eliminates PROGRESSION to class III and therefore class IV CHF for all new patients. What a significant impact on patients Quality of Life, Mortality and savings to the health system. Becoming more of a reality than a pipe dream thanks to our good friend MESOBLAST!
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-12060
-
- There are more pages in this discussion • 6,186 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
0.035(3.11%) |
Mkt cap ! $1.307B |
Open | High | Low | Value | Volume |
$1.13 | $1.17 | $1.13 | $1.474M | 1.280M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 22779 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 2503 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 9677 | 1.155 |
9 | 24242 | 1.150 |
8 | 36236 | 1.145 |
8 | 46367 | 1.140 |
4 | 46930 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.160 | 513 | 2 |
1.165 | 21400 | 6 |
1.170 | 63166 | 15 |
1.175 | 44600 | 7 |
1.180 | 57891 | 8 |
Last trade - 11.01am 30/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |